Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home

Refine search

Refine search

Access:
Content type:
Publication date:
Apply
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Send to Kindle
  • Send to Dropbox
  • Send to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

13 results

Multiple Sclerosis
  • Multiple Sclerosis
  • Recovery of Function and Neurorehabilitation
  • Edited by Jürg Kesselring, Giancarlo Comi, Alan J. Thompson
  • Published online: 05 August 2011
  • Print publication: 07 October 2010
  • View description
    Recent developments in basic and applied science have led to better understanding of disease mechanisms and more efficient therapies for multiple sclerosis. The most effective way of managing these patients is through a carefully planned neurorehabilitation programme. The main aims are to reduce disability and handicap and improve functions through effective training, stimulating activity and social participation. As the first text on recovery of function and neurorehabilitation in MS, this book focuses on mechanisms of recovery, application of neuroplasticity to therapeutic interventions, and determination of the efficiency of these interventions. Basic principles of neurorehabilitation in MS are described, as well as techniques for treating specific syndromes which may occur in MS. Written and edited by leading clinicians and researchers, the book achieves an excellent balance between basic science, pathophysiology, and clinical rehabilitation. An essential resource for clinicians and therapists treating patients with multiple sclerosis, neurophysiologists, and health care advisors.
  • Foreword
    • By Giancarlo Comi, Director of the Department of Neurology and Clinical Neurophysiology, San Raffael Hospital, Milan, Italy
  • Anthony Feinstein, University of Toronto
  • Book: The Clinical Neuropsychiatry of Multiple Sclerosis
  • Published online: 13 August 2009
  • Print publication: 17 May 2007, pp vii-viii
  • View extract

    Summary

    Among neurological disorders, multiple sclerosis has the unfortunate honor of being the most frequent cause of disability in young individuals. With the evolution of the disease, the brain is progressively deprived of sensory inputs and largely loses the ability to produce adequate responses. A combination of inflammation and degeneration causes progressive brain and spinal cord atrophy, which starts very early in the disease course and increases during the disease process. In addition, widespread damage takes place in the surviving gray and white matter. Not surprisingly, the disease often impacts on higher brain functions with neuropsychiatric manifestations. These processes are all admirably reviewed in this book and, for each cognitive and psychiatric disorder, the physiopathological theories are extensively and critically examined, making the book very useful not only for physicians, but also for researchers. The exceptional experience of Anthony Feinstein in this area, demonstrated by many key papers produced in the last decade, emerges clearly, page after page: the analysis of the literature is always combined with the “personal” view and a very useful summary of the main findings.

    There are many reasons why neuropsychiatric disorders assume a key role in the management of multiple sclerosis patients: they occur early and affect about half of the patients; they are the most frequent cause of unemployment and a major determinant of a reduced quality of life; moreover, they negatively affect the ability of the patients to adhere to therapeutic protocols and to benefit from the most recent advances in both etiologic and somatic treatment.